A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Metocurine
Sulfamethazine
The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfamethazine.
Metocurine
Sulfamerazine
The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfamerazine.
Metocurine
Ertugliflozin
The therapeutic efficacy of Empagliflozin can be increased when used in combination with Ertugliflozin.
Metocurine
Lacidipine
Empagliflozin may increase the hypotensive activities of Lacidipine.
Metocurine
Sacubitril
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Sacubitril.
Metocurine
Moxonidine
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Moxonidine.
Metocurine
Indoramin
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Indoramin.
Metocurine
Pipamperone
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Pipamperone.
Metocurine
Fimasartan
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Fimasartan.
Metocurine
Nitrous acid
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Nitrous acid.
Metocurine
Dinutuximab
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Dinutuximab.
Metocurine
Isoxsuprine
The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Empagliflozin.
Metocurine
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Empagliflozin.
Metocurine
Azilsartan medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Empagliflozin.
Metocurine
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Empagliflozin.
Metocurine
Nesiritide
The risk or severity of adverse effects can be increased when Nesiritide is combined with Empagliflozin.
Metocurine
Amyl Nitrite
The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Empagliflozin.
Metocurine
Barbexaclone
Barbexaclone may increase the hypotensive activities of Empagliflozin.
Metocurine
Barbital
Barbital may increase the hypotensive activities of Empagliflozin.
Metocurine
Hexobarbital
Hexobarbital may increase the hypotensive activities of Empagliflozin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3